Hem › Glioblastom › Pennsylvania
Kliniska studier för Glioblastom i Pennsylvania
21 studier för Glioblastom söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Penn State Health Milton S. Hershey Medical Center, Hershey
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05902169Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Allegheny Health Network, Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT03970447Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
RekryterarFas 1/2
Upp till ålder 25 · Alla kön · Uppdaterad 25 sep. 2026 · NCT04094610Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pennsylvania, Philadelphia
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06613841Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital of Philadelphia, Philadelphia
RekryterarObservationsstudie
12 Months – 39 Years · Alla kön · Uppdaterad 8 sep. 2026 · NCT05839379Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06860594Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Thomas Jefferson University Hospital, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- University of Pittsburgh Medical Center, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT02977780WBSI Guided Personalized Delivery of TTFields
- Abramson Cancer Center, Philadelphia
- Penn Medicine, University of Pennsylvania, Philadelphia
Rekryterar
Ålder 22 och äldre · Alla kön · Uppdaterad 6 aug. 2026 · NCT05086497Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
- Penn State Milton S. Hershey Medical Center, Hershey
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 17 juli 2026 · NCT07225621DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- UPMC Presbyterian Hospital, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juli 2026 · NCT06805305Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital of Philadelphia, Philadelphia
RekryterarTidig fas 1Friska volontärer välkomna
Ålder 1 till 21 · Alla kön · Uppdaterad 29 juni 2026 · NCT06333899Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Pittsburg Medical Center (UPCM), Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 11 juni 2026 · NCT05283330ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1
Ålder 2 till 21 · Alla kön · Uppdaterad 11 juni 2026 · NCT04732065Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 29 maj 2026 · NCT05843253SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Penn State Milton S. Hershey Medical Center, Hershey
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 27 juni 2025 · NCT03175224Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.